The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Surprisingly, businesswire.com at times has useful items on CRC

coloCan
coloCan CSN Member Posts: 1,944 Member
edited March 2014 in Colorectal Cancer #1
such as that of 1/18 pertaining to a Phase I clinicl trial at Johns Hopkins Univ Hosp, Duke Univ Med Center and North Shore Long Island Jewish Med Center for NPC-1C-Ensituximab--

"Data on Neogenix Oncology's Novel Therapeutic Antibody NPC-1C.........."



Today, this site carried an article titled "Merck Serono: Erbitux Long-Term Survival Benefit for mCRC Patients Confirmed With Folfox", which some might find informative.......steve
Like Care

Comments

Discussion Boards